In addition to these two genes, alteration of SMAD4 has been identified in a subset of patients with HHT and juvenile polyposis (approximately 2% of cases), a condition termed PJ-HHT syndrome, in which juvenile polyps and anemia are the predominant clinical features. Here, SMAD4 is linked to hereditary hemorrhagic telangiectasia.